Perfil clínico e uso de coberturas no manejo de lesões neoplásicas em pacientes oncológicos atendidos em ambulatório de estomaterapia
Revista ft · 30.07.2026 · 30 (160) · 01-17
DOI: 10.69849/2tfdre74 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 30.07.2026. Verfasst von Eliene Maria de Jesus Santos und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
specialized service, with emphasis on diagnoses and dressings used in lesion management, from 2021 to 2022.
Method
Observational, descriptive, retrospective study with a quantitative approach, conducted from the analysis of care records referring to the years 2021 and 2022. Patients with a confirmed oncological diagnosis and complete records containing sex, age, diagnosis, and topical therapy used were included. Descriptive statistical analysis was performed, presenting absolute and relative frequencies, as well as measures of central tendency and dispersion.
Results
Forty-three patients were analyzed, of whom 33 (76.7%) were female and 10 (23.3%) were male, with ages ranging from 35 to 93 years and a mean of 63 years. Breast cancer was the most frequent diagnosis, corresponding to 30 (69.8%) cases, with 16 (80.0%) of the 20 cases registered in 2021 and 14 (60.9%) of the 23 cases in 2022. In 2022, greater diagnostic diversity was observed, including adenocarcinoma of the lower rectum and squamous cell carcinoma of the oropharynx and larynx (3 cases; 13.0% each), in addition to non-Hodgkin lymphoma, chest wall sarcoma, and scalp cancer (1 case; 4.3% each). Alginate was the most frequently used dressing, present in 30 (69.7%) patients, followed by topical metronidazole in 9 (20.9%), silver sulfadiazine in 7 (16.2%), potassium permanganate in 4 (9.3%), barrier cream and simple protection in 2 (4.6%) patients each, and hydrofiber with silver, petrolatum, and absorbent in 1 (2.3%) patient each. The frequent use of combined therapies was also observed, especially associations between alginate, metronidazole, and silver sulfadiazine, aimed at controlling exudate, odor, and local infection.
Conclusion
The findings highlight a care profile characterized by a predominance of women (76.7%), a high frequency of breast cancer (69.8%), and an increase in diagnostic diversity throughout the study period. The predominance of alginate use, alone or in combination with antimicrobial therapies, demonstrates alignment of care practices with evidence-based recommendations for the management of neoplastic lesions, reinforcing the importance of the Nursing Care Systematization and institutional planning in improving the quality of care.
Zitieren
APA
Santos, E. M. D. J., Moreira, G. B. T., & Lino, A. I. D. A. (2026). Perfil clínico e uso de coberturas no manejo de lesões neoplásicas em pacientes oncológicos atendidos em ambulatório de estomaterapia. Revista ft, 30(160), 01-17. https://doi.org/10.69849/2tfdre74
Vancouver
Santos EMDJ, Moreira GBT, Lino AIDA. Perfil clínico e uso de coberturas no manejo de lesões neoplásicas em pacientes oncológicos atendidos em ambulatório de estomaterapia. Revista ft. 2026;30(160):01-17. doi:10.69849/2tfdre74
BibTeX
@article{Santos2026,
author = {Santos, Eliene Maria de Jesus and Moreira, Geislaine Beatriz Tavares and Lino, Alexandra Isabel de Amorim},
title = {Perfil clínico e uso de coberturas no manejo de lesões neoplásicas em pacientes oncológicos atendidos em ambulatório de estomaterapia},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {160},
pages = {01--17},
doi = {10.69849/2tfdre74}
}
EUVIMED